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I N T R O D U C T I O N
Glutamate is one of major excitatory neurotransmitters in the CNS. The receptors are classified as ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs) . The iGluRs mediate fast synaptic transmission through ligand-gated ion channels, and the mGluRs are coupled to second-messenger systems that are responsible for slower synaptic events. Recently eight mGluR subtypes have been cloned (mGluR1-mGluR8) (Pin and Duvosin 1995; Riedel 1996) . The mGluRs have been further divided into three main groups according to their sequence homology, signal transduction mechanism, and agonist selectivity. The mGluR subgroup I includes mGluR1 and mGluR5, which are coupled to phosphoinositide hydrolysis (Abe et al. 1992 ). Subgroup II (mGluRII) contains mGluR2 and mGluR3, and subgroup III (mGluRIII) includes mGluR4, mGluR6 -mGluR8. Both mGluRII and mGluRIII are negatively coupled to adenylyl cyclase (AC) (Tanabe et al. 1992 (Tanabe et al. , 1993 . The modulations of these mGluRs on synaptic transmission enhance or suppress the release of inhibitory and excitatory neurotransmitters, such as GABA and glutamate, from nerve terminals (Glitsch et al. 1996; Poncer et al. 1995) . Several reports show that these actions involve multiple mechanisms. For example, mGluRs inhibit Ca 2ϩ channels or activate the K ϩ channels of presynaptic terminals (Cochilla and Alford 1998; Takahashi et al. 1996) . Also, the mGluRs have direct effects on the vesicle releasing mechanism (Poncer et al. 1995) and elicit Ca 2ϩ release from presynaptic Ca 2ϩ stores (Peng 1996) . Most mGluRs, with exception of mGluR6 and mGluR8, are distributed throughout the spinal cord (Valerio 1997; Watkins and Evans 1981) . These mGluRs have dual effects on the synaptic transmission in the spinal cord, potentiating or suppressing the release of excitatory or inhibitory neurotransmitters (Bond and Lodge 1995; Cao et al. 1997; Jane et al. 1996; King and Liu 1996) . The sacral dorsal commissural nucleus (SDCN) of spinal cord surrounding the central canal receives abundant afferent inputs from both the visceral and somatic organs. The convergence of the visceral and somatic inputs on neurons in the SDCN has been demonstrated electrophysiologically and anatomically (Honda 1985) . Also, the SDCN is known to be involved in nociceptive, analgesic transmission and autonomic functions of visceral and somatic inputs (Ding et al. 1994; Honda 1985; Vizzard et al. 1995) . In the SDCN area, glycine is one of the major inhibitory neurotransmitters (Basbaum 1988; Yoshimura and Nishi 1995) . However, the releasing mechanism of glycine from glycinergic presynaptic terminals projecting to the SDCN neurons is poorly understood. The intracellular signaling mechanisms underlying the mGluR modulation of glycine release are also not known.
In the present study therefore, we investigated the mechanism of the mGluR modulation of the spontaneous miniature glycinergic inhibitory postsynaptic currents (mIPSCs). The preparations made from mechanically dissociated rat SDCN neurons attached with native presynaptic boutons were used that combine the advantages of a simple, reduced system while maintaining native synaptic functions. The activation of metabotropic glutamate receptors on the presynaptic glycinergic terminals reduces transmitter release by interfering with cAMP/PKA pathway.
M E T H O D S

Mechanical dissociation
Ten-to 14-day-old Wistar rats were decapitated under pentobarbital anesthesia. The spinal cord was quickly removed from the vertebral canal and was sliced at a thickness of 400 m with a microslicer (DTK-1000, Dosaka, Kyoto, Japan). The slices were kept in the incubation medium saturated with 95% O 2 -5% CO 2 at room temperature (22-25°C) for Ն1 h. Thereafter the slices were transferred into a 35-mm culture dish (Primaria3801, Becton Dickinson, NJ) and the SDCN of the spinal cord was identified under a binocular microscope (SMZ-1, Nikon, Tokyo). A fire-polished glass pipette was touched lightly onto the surface of the SDCN region and was vibrated horizontally at 3-5 Hz for ϳ2 min by apparatus developed by our laboratory. Then the slices were removed from the dish. The mechanically dissociated SDCN neurons adhered to the bottom of the dish within 10 min. These neurons, which were dissociated without using any enzymes, retained their original morphological features, including proximal dendritic processes.
Slice preparation
Thirteen-to 15-day-old Wistar rats were decapitated under pentobarbital anesthesia. The spinal cord was quickly removed from the skull and was sliced at a thickness of 230 m with a microslicer (VT-1000S, Leica, Germany) in cold Na ϩ -free (including sucrose) medium. Then the slices were kept in incubation medium saturated well with 95% O 2 -5% CO 2 at 30 -35°C for ϳ1 h. Thereafter the slices were transferred into a recording chamber, and the SDCN of the spinal cord was identified under an upright microscope (Axioscope, Zeiss, Germany). The bath solution was perfused at 8 -10 ml/min.
All experiments conformed the Guiding Principles for the Care and Use of Animals approved by the Council of the physiological Society of Japan, and all efforts were made to minimize the number of animals used and their suffering.
Electrical measurements
Electrical measurements were performed in the dissociated neurons attached with synaptic boutons using the nystatin-perforated-patch recording mode and in the slice preparation using the whole cell patch recording mode under voltage-clamp conditions. The nystatin-perforated-patch technique but not whole cell patch technique was applied to dissociated neuron. When the nystatin-perforated-patch recording mode was applied to the dissociated neurons, the technique allows a long time recordings not by like conventional whole cell patch recording mode. However, the conventional whole cell patch recording mode was used for slice preparation. In this preparation, either nystatin-or whole cell patch technique is enough to record cell response for Ն3 h because the conventional whole cell patch technique was much easier and convenient to record the responses from slice preparation. Patch pipettes were made from borosilicate glass tubes (1.5 mm OD, 0.9 mm ID; G-1.5, Narishige, Tokyo) in two stages on a vertical pipette puller (PB-7, Narishige). The resistance of the recording electrode was 5-7 M⍀. The neurons were visualized with phasecontrast equipment on an inverted microscope (Diapot, Nikon). The current and voltage were measured with a patch-clamp amplifier (EPC-7, List-Electronic, Germany), monitored on both an oscilloscope (Tektronix 5111A, Sony, Tokyo) and a pen recorder (RectiHoriz 8K, Nippondenki San-ei, Tokyo), and stored on videotapes (PCM-501 ES, Sony). The membrane currents were filtered at 1 kHz (E-3201A Decade Filter, NF Electronic Instruments, Tokyo), and data were digitized at 4 kHz. The evoked obtained were performed by applying short (100 s) voltage pulses at 0.1 Hz through glass pipette (: 10 m), which was placed around central canal and filled with the incubation solution, using the PULSE program on a Macintosh computer (HEKA). The signals were filtered at 3 kHz and digitized at 10 kHz.
Data analysis
Events were counted and analyzed using DETECTiVENT (Ankri et al. 1994) and IGOR PRO software (Wavemetrics, Lake Oswego, OR), and the time to peak and decay time of individual mIPSCs were analyzed using pCLAMP software (Axon Instruments). Analysis of mIPSCs was performed with cumulative probability plots. Cumulative amplitude histograms were compared using the Kolmogorov-Smirnov test for significant difference (P Ͻ 0.05). Numerical values are provided as means Ϯ SE. Differences in amplitude and frequency distribution were tested by paired two-tailed t-test.
Solutions
The ionic composition of the incubation medium was (in mM) 124 NaCl, 5 KCl, 1.2 KH 2 PO 4 , 24 NaHCO 3 , 2.4 CaCl 2 , 1.3 MgSO 4 , and 10 glucose. The pH of the incubation medium was adjusted to 7.4 with 95% O 2 -5% CO 2 . The ionic composition of the external standard solution was (in mM) 150 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES. Ca 2ϩ -free external solution contained (in mM) 150 NaCl, 5 KCl, 3 MgCl 2 , 10 glucose, 10 HEPES, and 2 EGTA. The ionic composition of the Na ϩ -free medium was (in mM) 230 sucrose, 2.5 KCl, 1.25 Na 2 HPO 4 , 10 MgSO 4 , 0.5 CaCl 2 , 26 NaHCO 3 , and 30 glucose. The composition of K ϩ -free external solution was (in mM) 147 NaCl, 5 CsCl, 5 BaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES. These external solutions were adjusted pH 7.2 with Tris-OH.
In recording mIPSCs, these solutions routinely contained 3 ϫ 10
Ϫ7
M tetrodotoxin (TTX) to block voltage-dependent Na ϩ channels, 3 ϫ 10 Ϫ6 M bicuculline to block the GABA A response, and 10 Ϫ6 M 6-cyano-7-nitroquinoxaline-2, 3-dione (CNQX) and 10 Ϫ5 M DLϪ2-amino-5-phosphovaleric acid (DL-AP5) to block glutamatergic responses. The ionic composition of the internal (patch pipette) solution for the nystatin-perforated-patch recording was (in mM) 20 N-methyl-D-glucamine methanesulfonate, 20 Cs-methanesulfonate, 5 MgCl 2 , 100 CsCl, and 10 HEPES. The pH of internal solution was adjusted to 7.2 with Tris-OH. Nystatin was dissolved in acidified methanol at 10 mg/ml. The stock solution was diluted with internal solution just before use to a final concentration of 100 -200 g/ml. The ionic composition of the internal (patch pipette) solution for the whole cell patch recording was (in mM) 43 CsCl, 92 Cs-methanesulfonate, 5 TEA-Cl, 2 EGTA, 4 ATP-Mg, and 10 HEPES. The pH of internal solution was adjusted to 7.2 with Tris-OH.
Drugs
Drugs used in the present study were AP5, bicuculline, CNQX, EGTA, nystatin, forskolin, 1,9-dideoxy-forskolin, 8Br-cAMP, SpcAMP, Rp-cAMP, and ␣-bungarotoxin (Sigma); ATP (Yamasa, Japan); TTX and strychnine (Wako Pure Chemicals, Japan); and 2-amino-4-phosphonobutyrate (L-AP4), (2S, 1ЈS, 2ЈS)-2-(carboxycyclo propyl) glycine (L-CCG-I), ␣-methyl-1-(2S, 1ЈS, 2ЈS)-2-(carboxycyclo propyl) glycine (MCCG), and (RS)-␣-cyclopropyl-4-phosphonophenylglycine (CPPG) (Tocris, UK).
R E S U L T S
Spontaneous glycinergic mIPSCs
The spontaneous postsynaptic currents were recorded from the acutely dissociated rat SDCN neurons attached with the native presynaptic nerve endings, namely "synaptic bouton preparation." The recording utilized the nystatin-perforatedpatch recording mode at a holding potential (V H ) of Ϫ60 mV. Strychnine abolished the spontaneous inhibitory currents in a reversible and a dose-dependent manner in the presence of 3 ϫ 10 Ϫ7 M TTX, 10 Ϫ5 M 2-amino-5-phosphonovaleric acid, 10
Ϫ6
M CNQX, and 10 Ϫ6 M bicuculline (Fig. 1A ). Since it is reported that strychnine is also a potent competitive antagonist of nicotinic acetylcholine receptors (nAChRs) having ␣7 subunits in the rat hippocampal neurons (Matsubayashi et al. 1998), we examined whether SDCN neurons have nicotinic components or not. Thus the effect of ␣-bungarotoxin (␣-BTx) (10 Ϫ7 M), a selective antagonist of ␣7-containing nAChRs, was tested on the spontaneous postsynaptic current. The ␣-BTx did not alter the frequency or amplitude of the mIPSCs, indicating that nicotinic component does not exist (data not shown).
Representative spontaneous glycinergic mIPSCs were also investigated at various V H s (Fig. 1B) . The average current amplitude of the mIPSCs during the 3-min sampling period was plotted against to each V H s. The reversal potential of mIPSCs estimated from the current-voltage (I-V) relationship was about Ϫ10 mV. The value was almost identical to the theoretical Cl Ϫ equilibrium potential (E Cl ) of Ϫ10. (Fig. 1Bb) . These data clearly indicate that the spontaneous miniature postsynaptic currents are glycinergic mIPSCs.
Inhibitory effect of tACPD on glycinergic mIPSCs
The effect of trans-ACPD (tACPD), a metabotropic glutamate agonist, on glycinergic mIPSCs was examined. In the present study, SDCN neurons were subdivided to three groups according to the cell size: i.e., small (Ͻ15 m), middle (15-30 m), and large (Ͼ30 m). Among 92 dissociated SCDN neurons in the presence of 10 Ϫ5 M tACPD, the mIPSC frequency decreased in 69 neurons, which were middle-and large-size neurons. The tACPD increased the mIPSC frequency in 13 small neurons. There was no change in 10 neurons, which were small-and middle-size neurons. In the following experiments, therefore we used the middle-size neurons.
The tACPD (10 Ϫ5 M) reversibly suppressed mIPSC frequency but had no effect on the distribution of the current amplitudes (Fig. 2, A and C) , indicating that the probability of glycine release decreased. In fact, the mIPSC frequency significantly decreased to 72.7 Ϯ 1.7% of control (P Ͻ 0.01, n ϭ 69) in the presence of tACPD, whereas the mean mIPSC amplitude was 100.8 Ϯ 1.3% of control (n ϭ 69; Fig. 2B ). Figure 2C indicates the superimposed amplitude histograms of mIPSCs with (Ⅲ) or without (▫) tACPD for 3 min. The amplitude distribution of the mIPSCs was skewed toward largeamplitude events. There was a clear decrease in the number of mIPSC events at all amplitudes in the presence of tACPD. However, no significant difference in the distribution of mIPSC amplitudes was detected between control and tACPDtreated neurons (P ϭ 0.4328 by Kolmogorov-Smirnov test, number of events 297 for control and 187 for tACPD). Figure  2C , inset, shows the superimposed typical mIPSCs with or without tACPD. The decay time, , was measured and averaged for 38 individual events in each neuron for control and tACPD-treated neurons. Both decay times of each group were fitted by a single-exponential function. The means of values for control and tACPD-treated neurons were 19.6 Ϯ 1.3 and 18.8 Ϯ 1.1 ms (n ϭ 9), respectively. There was no significant difference in the time to peak and values between control and tACPD-treated neurons. These results suggest that mGluR exists in the glycinergic nerve terminal and exerts an inhibitory effect on the presynaptic glycine release process without affecting the sensitivity of postsynaptic glycine receptors.
Presynaptic mechanism of tACPD in glycinergic nerve terminal
Three kinds of inhibitory mechanisms could account for the effect of tACPD on glycine release. First, tACPD might suppress Ca 2ϩ influxes through voltage-dependent Ca 2ϩ channels (VDCCs) in the nerve terminal, resulting in decrease in exocytosis (Morishige et al. 1996; Takahashi et al. 1996) . Second, tACPD might open K ϩ channels, thus hyperpolarizing the presynaptic membrane and reducing synaptic release (Cochilla and Alford 1998) . Third, the agonist might activate intracellular messenger pathways that inhibit the release mechanism in presynaptic terminals (Trudeau et al. 1996a,b) . We, therefore examined the possible contribution of presynaptic VDCCs in the mediation of tACPD action on mIPSC. The removal of Ca 2ϩ from external solution significantly decreased mIPSC frequency without affecting the distribution of their current amplitudes. Figure 3Aa shows a typical response of mIPSCs before, during, and after the application of tACPD in Ca 2ϩ -free external solution. tACPD decreased the mIPSCs frequency in a reversible manner without affecting the distribution of the current amplitudes (Fig. 3Ab) . The inhibition of mIPSC frequency by tACPD was 77.8 Ϯ 4.3% of control even in the Ca 2ϩ -free solution (P Ͻ 0.05, n ϭ 5). Moreover, the application of 100 M Cd 2ϩ , which completely blocks VDCCs, also failed to remove the inhibitory effect of tACPD on mIPSCs frequency (Fig. 3B) . The inhibition was almost the same as that in Ca 2ϩ -free solution (78.3 Ϯ 4.5% of control, n ϭ 5). The data suggest that the inhibitory effect of mGluRs in the presence of tACPD is independent of Ca 2ϩ influxes passing through VDCC. It was investigated that the possible role of presynaptic K ϩ channels in the mediation of tACPD action on mIPSC frequency. Figure 4A shows the relationship between external K ϩ concentration ([K ϩ ] o ) and spontaneous IPSCs frequency with or without TTX in the standard solution. The removal of K ϩ from the control solution slightly increased mIPSC frequency (P Ͻ 0.05, n ϭ 5; Fig. 4A ) but did not affect the distribution of the current amplitudes (data not shown). Figure 4Ba shows a typical response of mIPSCs before, during, and after the application of tACPD in K ϩ -free external solution, containing both Ba 2ϩ and Cs ϩ to block the K ϩ conductance. Even in this K ϩ -channel-blocking solution, tACPD reversibly suppressed mIPSC frequency to 78.6 Ϯ 6.8% of control (P Ͻ 0.05, n ϭ 6) but had no effect on the distribution of current amplitudes (Fig. 4B, b and c) . The results suggest that the inhibitory effect of tACPD on mIPSC frequency is not due to the increase of presynaptic K ϩ conductance.
The last possibility is a presynaptic inhibition mediated through an intracellular signaling mechanism. The mGluRs could alter synaptic transmission by coupling to phosphoinositide hydrolysis or to adenylyl cyclase (AC) pathways via heterotrimeric G protein (Tanabe et al. 1992 (Tanabe et al. , 1993 M tACPD. The number of events used for cumulative distributions was 297 for control, 187 for tACPD, and 293 for after control during 3 min. B: statistical summary of results from the 69 neurons responded to 10 Ϫ5 M tACPD. All amplitudes and frequencies are normalized to those of control mIPSCs. The vertical bar shows ϮSE. **, statistically significant difference at P Ͻ 0.01. C: amplitude histograms from the Aa trace for control (▫) and 10 Ϫ5 M tACPD (o). Inset: individual mIPSCs in the same neuron before and after the application of tACPD were superimposed.
FIG. 3. Effect of tACPD in either Ca
2ϩ -free or Cd 2ϩ -external solution. Aa: recording of mIPSCs before, during, and after the application of 10 Ϫ5 M tACPD in Ca 2ϩ -free external solution. b: cumulative amplitude distribution (right) and cumulative frequency distribution (left) of mIPSCs in Ca 2ϩ -free external solution. B: averaged inhibition ratios of amplitude (right) and frequency (left) with tACPD, Ca 2ϩ -free plus tACPD, and Cd 2ϩ plus tACPD. Each column is the mean of 5 neurons (**P Ͻ 0.01). The vertical bar shows ϮSE. 0.01, n ϭ 9) without affecting the mean mIPSC amplitude (111.8 Ϯ 8.4% of control, n ϭ 9, Fig. 5A, a and b) . After application of forskolin, it took 5 min for the frequency to become stable (Fig. 5Ab) . The result indicates that forskolin is acting at a glycinergic presynaptic site (Fig. 5, A and B) . The data also suggest that either cAMP or PKA might be related to the inhibition of glycine release from the presynaptic terminals.
Forskolin (10 Ϫ5 M) completely prevented tACPD action on the mIPSCs frequency (Fig. 6A, a and b) . Before the treatment of forskolin, tACPD reduced mIPSC frequency without affecting the mean mIPSC amplitude. During the treatment of forskolin in the same neuron, the inhibitory effect of tACPD on mIPSC frequency disappeared (102.4 Ϯ 8.7% to control, n ϭ 7) without altering the current amplitude (106.8 Ϯ 3.4% to control, n ϭ 7; Fig. 6, Ac and B) . Recent reports indicate that forskolin enhances glutamate release by not only activating AC but also by promoting a Ca 2ϩ influx mechanism (Hoshi et al. 1988; Lonart et al. 1998; Wagoner and Pallotta 1988) . Thus it was examined whether 1-9-dideoxy-forskolin, an inactive form of forskolin, has an inhibitory effect on glycine release from the nerve terminals. The inactive form itself potentiated the frequency of mIPSCs (191.0 Ϯ 33.0% of control, n ϭ 5) without altering the current amplitude distribution. But tACPD still had an inhibitory effect on mIPSCs frequency (91.4 Ϯ 5.3% of control, n ϭ 5, figure not shown). Therefore these results suggest that this change of synaptic efficacy by tACPD is elicited via AC-cAMP/PKA pathway. The effect of cAMP analogues was further examined to test the direct action of cAMP/PKA pathway. Both 8-Br-cAMP, membrane permeable cAMP activator and Sp-cAMP, membrane permeable PKA activator, increased the frequency of glycine release (126.8 Ϯ 6.9 and 133.1 Ϯ 5.4% of control, respectively, n ϭ 5). 8-Br-cAMP blocked completely the inhibitory action of tACPD (132.0 Ϯ 2.0% of control, n ϭ 5). Sp-cAMP, however, did not block the inhibitory effect of tACPD (96.0 Ϯ 1.7% of control, n ϭ 5). Rp-cAMP, a membrane permeable PKA inhibitor, facilitated the mIPSCs frequency (127.5 Ϯ 4.02% to control, n ϭ 5) without changing the current amplitude distribution (98.9 Ϯ 2.57% to control, n ϭ 5). Rp-cAMP, however, did not block the inhibitory effect of tACPD (96.7 Ϯ 2.91% of control, n ϭ 5; Fig. 6B ). Thus these results could be suggested that the inhibitory action of tACPD related to cAMP but not PKA. 
Subtype of mGluRs
To determine which subtypes of mGluRs participated in the inhibition of mIPSCs, the effects of mGluR agonists and antagonists were examined. Figure 7Aa shows the mIPSCs before, during, and after the application of a mGluRIII specific agonist, L-AP4 (10 Ϫ5 M). L-AP4 mimicked the action of tACPD, and the inhibitory effect of L-AP4 disappeared in the presence of 10 Ϫ4 M CPPG, a mGluRIII specific antagonist (Conn and Pin 1997) . The L-AP4 application decreased reversibly the mIPSC frequency to 74.1 Ϯ 4.2% of control (P Ͻ 0.01, n ϭ 12) without affecting the mean amplitude (Fig. 7B ). CPPG at 10 Ϫ4 M itself did not affect cumulative distributions of mIPSCs (data not shown). mGluRII-specific agonist, 10 Ϫ5 M L-CCG-I, also reduced mIPSC frequency (75.0 Ϯ 4.6% to control) without affecting the amplitude distribution in the same cells (Fig. 7B) . The inhibitory effect of L-CCG-I was blocked fully by 3 ϫ 10 Ϫ4 M MCCG, a specific mGluRII antagonist. These results indicate that the inhibitory effect of tACPD on the mIPSC frequency is mediated by at least mGluRII and/or mGluRIII in these glycinergic nerve terminals.
We also examined the effect of mGluR antagonists on tACPD action. CPPG (10 Ϫ4 M) reduced the inhibitory effect of tACPD (from 73.0 Ϯ 3.5 to 82.5 Ϯ 2.0% of control, n ϭ 4), and 3 ϫ 10 Ϫ4 M MCCG also relieved the tACPD action in the same cells (to 79.0 Ϯ 3.2% of control, n ϭ 4; Fig. 7C ). However, each antagonist did not completely block the inhibitory action of tACPD. The percent of inhibition by L-AP4 and L-CCG-I varied considerably among neurons. Some cells were only sensitive to one agonist, suggesting that the nerve endings of SDCN neurons have only one type of mGluRs. However, most cells were sensitive to both L-AP4 and L-CCG-I. Thus these data suggest that the mGluR subtypes such as mGluRII and mGluRIII in the glycinergic nerve terminals projecting on SDCN neuron exist heterogeneously.
We also examined the existence of mGluRII and/or mGluRIII on glycinergic nerve terminal in the slice preparation using the whole cell patch recording technique at V H of Ϫ60 mV. SDCN neurons had also been subdivided to three groups according to the cell size as that observed in dissociated SDCN neurons. Therefore the experiment was performed on the same middle size neurons. Figure 8Aa shows that the glycinergic eIPSC before, during, and after the application of 10 Ϫ6 M L-CCG-I and 10 Ϫ6 M L-AP4, respectively. The application of L-CCG-I decreased reversibly the eIPSC amplitude (47.9 Ϯ 3.9% of control, n ϭ 6). After wash out, when the eIPSC amplitude recovered on control baseline, L-AP4 was applied. L-AP4 also decreased reversibly the eIPSC amplitude (50.0 Ϯ 4.4% of control, n ϭ 6, Fig. 8Ab) . Figure 8Ba shows effects of 10 Ϫ6 M L-CCG-I and L-AP4 on glycinergic mIPSCs of the slice preparation in the presence of TTX. Both L-CCG-I and L-AP4 decreased reversibly the mIPSC frequency (47.9 Ϯ 5.9, 54.6 Ϯ 6.4% of control, respectively, n ϭ 5) without affecting its current amplitude (Fig.  8Bb) .
These results indicate that the inhibitory effects of mGluR on eIPSC amplitude and mIPSC frequency are mediated by the function of both mGluRII and mGluRIII in these glycinergic nerve terminals. Thus these data suggest that the mGluR subtypes such as mGluRII and mGluRIII in the glycinergic nerve terminals projecting on SDCN neuron also exist heterogeneously in the slice preparation.
D I S C U S S I O N
Multisynapses on the dissociated single neuron
In the present study, the slice preparation and the mechanically dissociated neurons without treating any enzymes were used. The "synaptic bouton preparation" preserves native synaptic boutons on isolated SDCN cell bodies. Using pharmacological isolation of the glycinergic IPSCs, the functional modulation of glycine release mediated by mGluRs. The amplitude distribution of the mIPSCs was skewed toward large amplitude events (Fig. 2) , indicating that the dissociated single neuron has multiple intact functional synapses. The data are consistent with recordings from slice preparation (Zhou and Hablitz 1997) . TTX reversibly decreased mIPSC frequency to 45.5% of control (P Ͻ 0.01, n ϭ 52) but had no effect on the distribution of their current amplitudes. The decrease of mIPSCs frequency was not accompanied by a change in the current amplitude, indicating that the probability of glycine release decreases in the presence of TTX. In addition, TTX-sensitive Na ϩ channels that contribute to spontaneous glycine release in this isolated preparation evidently exist quite near to the nerve terminals.
Inhibitory mechanism of tACPD
It is reported that activation of K ϩ conductance and/or reduction of voltage-dependent Ca 2ϩ currents induce presynaptic inhibition (Cochilla and Alford 1998; Takahashi et al. 1996) . Figure 4A shows (Shirasaki et al. 1994) . In the present experiment, using an internal solution with Cs ϩ instead of K ϩ , the activation of postsynaptic K ϩ channels could be excluded. In any case, the quantitative and kinetic analysis showed that tACPD suppressed only mIPSC frequency, but not the current amplitude, and that tACPD did not change time to peak or the decay time course of individual mIPSCs. These results indicate that tACPD acts selectively on the presynaptic glycine release process without altering postsynaptic glycine receptor sensitivity.
The VDCCs in the active zone of synapses are found in dense aggregates that have an important role in the triggering or the modulation of transmitter release in presynaptic nerve terminals (Haage et al. 1998; Stanley 1997; Takahashi et al. 1996) . VDCC subtypes such as N, P, and/or Q types participate in the inhibitory modulation of excitatory synaptic transmission in nerve endings of CNS (Huang et al. 1996; Poncer et al. 1997 ). In our experiment, Ca 2ϩ influxes via VDCC at the glycinergic presynaptic terminals did not contribute to the inhibitory effect of tACPD on mIPSCs since the tACPD inhibition of mIPSC frequency did not alter in either Ca 2ϩ -free or Cd 2ϩ -external solution.
The modulation of transmitter release by a Ca 2ϩ -independent mechanism has been also reported recently (Thomson et al. 1993; Trudeau et al. 1996a,b) . Some studies revealed that the increase of cAMP/PKA directly activated presynaptic transmission in rat CNS neurons (Capogna et al. 1995; ChavezNoriega and Stevens 1994; Chen and Regher 1997; Trudeau et al. 1996a,b) . In the present experiment, the effect of tACPD was blocked by forskolin, which activates the AC cascade leading to cAMP activation of PKA (Zhang et al. 1997) . tACPD, however, decreased glycine release in the presence of Sp-cAMP, a cAMP analogue that directly activated PKA. On the other hand, 8-Br-cAMP blocked the inhibitory effect of tACPD. Evidently, the cAMP receptor responsible for the increase in transmitter release is much more sensitive to 8-BrcAMP than to Sp-cAMP. Thus cAMP itself contributes to presynaptic glycine release and the presynaptic inhibitory effect of tACPD could be mediated by decreasing the intracellular cAMP concentration ([cAMP] i ) level. Therefore present results suggest that the inhibitory action of mGluR is mediated by the decrease of [cAMP] i but not the reduction of PKA in the nerve terminals.
Distribution of mGluR subtypes
The present study suggests that both mGluRII and mGluRIII exist in the presynaptic terminals of majority of SDCN neurons (Figs. 7 and 8) . tACPD, L-AP4, and L-CCG-I reversibly suppressed the mIPSC frequency but had no effect on the distribution of the current amplitude in the dissociated neuron and also suppressed both mIPSC frequency and eIPSC amplitude in the slice preparation. The mean inhibition induced by tACPD, L-AP4, and L-CCG-I was almost the same, and yet mGluR antagonists alone could not block the inhibitory action of tACPD. Thus it was considered the possibility of three models about the various distributions of their mGluRs in the synaptic terminals. First, the postsynaptic neuron may have several presynaptic terminals in which each terminal has only one kind of mGluR subtypes (mGluRII or mGluRIII). Second, one kind of mGluR subtype may have an effect on each terminal, but the terminals with different subtypes are variously distributed on postsynaptic neurons. And last, the mGluR subtypes may coexist in the same presynaptic nerve terminal. In the present experiments, a few cells responded to only one of mGluR subtypes. However, the distribution of the magnitudes of the inhibition by each of the agonists varied considerably among the middle size cells tested, suggesting that most of SDCN neurons may have a heterogeneous distribution of presynaptic mGluR subtypes.
The first and third hypotheses could be supported by the slice experiment because both mGluRII and III agonists modulated the evoked glycine release in all neurons tested. These results suggest that if only the nerve ending coexisting of both mGluR subtypes was stimulated, the evoked glycine release could be modulated by both of agonists. On the other hand, if a few nerve endings in spite of existence of one kind of different mGluR subtype in each terminal were stimulated, the evoked glycine release could be also modulated by both of agonists.
Physiological role
SDCN receives abundant inputs from the raphe, locus coeruleus, and hypothalamus. The innervation of the sensory afferents to the SDCN region is involved in nociceptive transmission. The SDCN neurons could be subdivided into three regions according to the effective somatic and/or visceral inputs (Honda 1985) . The size of neurons responsive to somatic stimulation (SOM neurons) was between 15 and 50 m, while the neurons responsive to visceral (VISC neurons) or to both somatic and visceral stimulation (SOMVISC neurons) was Ͻ15 m (Honda 1985) . Thus the middle-size neurons used in the present experiments might be visceral neuron or somatic visceral neurons.
In the present study, tACPD induced presynaptic inhibition in the glycinergic nerve terminal of the dissociated SDCN neurons. The inhibition of glycine release might result in the depolarization of the postsynaptic VISC or SOMVISC neurons. Such a change of synaptic efficacy might enhance the sensation of pain from the visceral and somatic organs, resulting in hyperalgesia.
